Justine Mailliot

Dr. Justine Mailliot

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2017 in WIREs RNA
Verified
Journal Article
Closed access
PDF file
JMJustine Mailliot
Justine Mailliot
Franck MARTINFranck MARTIN
Franck MARTIN

8 November 2016 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
SMSergey Melnikov
Sergey Melnikov
JMJustine Mailliot
Justine Mailliot
LRLukas Rigger
Lukas Rigger
SNSandro Neuner
Sandro Neuner
BSByung‐Sik Shin
Byung‐Sik Shin
MYMarat Yusupov
Marat Yusupov

22 June 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PSPatrick Schaub
Patrick Schaub
QYQiuju Yu
Qiuju Yu
SGSandra Gemmecker
Sandra Gemmecker
PPPierre Poussin-Courmontagne
Pierre Poussin-Courmontagne
JMJustine Mailliot
Justine Mailliot
PBPeter Beyer
Peter Beyer
CRTI-type phytoene desaturases prevailing in bacteria and fungi can form lycopene directly from phytoene while plants employ two distinct desaturases and two cis-tans isomerases for the same purpose. This property renders CRTI a valuable gene to engineer provitamin A-formation to help combat vitamin A malnutrition, such as with Golden Rice. To understand the biochemical processes involved, recombinant CRTI was produced and obtained in homogeneous form that shows high enzymatic activity with the lipophilic substrate phytoene contained in phosphatidyl-choline (PC) liposome membranes. The first crystal structure of apo-CRTI reveals that CRTI belongs to the flavoprotein superfamily comprising protoporphyrinogen IX oxidoreductase and monoamine oxidase. CRTI is a membrane-peripheral oxidoreductase which utilizes FAD as the sole redox-active cofactor. Oxygen, replaceable by quinones in its absence, is needed as the terminal electron acceptor. FAD, besides its catalytic role also displays a structural function by enabling the formation of enzymatically active CRTI membrane associates. Under anaerobic conditions the enzyme can act as a carotene cis-trans isomerase. In silico-docking experiments yielded information on substrate binding sites, potential catalytic residues and is in favor of single half-site recognition of the symmetrical C40 hydrocarbon substrate.

1 September 2016 in Journal of Molecular Biology
Verified
Journal Article
Closed access
SMSergey Melnikov
Sergey Melnikov
JMJustine Mailliot
Justine Mailliot
BSByung-Sik Shin
Byung-Sik Shin
LRLukas Rigger
Lukas Rigger
GYGulnara Yusupova
Gulnara Yusupova
MYMarat Yusupov
Marat Yusupov

27 February 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
LSLingling Sun
Lingling Sun
JMJustine Mailliot
Justine Mailliot
CSChristiane Schaffitzel
Christiane Schaffitzel
Nonsense-mediated mRNA decay (NMD) is a cellular surveillance mechanism that degrades mRNAs with a premature stop codon, avoiding the synthesis of C-terminally truncated proteins. In addition to faulty mRNAs, NMD recognises ~10% of endogenous transcripts in human cells and downregulates their expression. The up-frameshift proteins are core NMD factors and are conserved from yeast to human in structure and function. In mammals, NMD diversified into different pathways that target different mRNAs employing additional NMD factors. Here, we review our current understanding of molecular mechanisms and cellular roles of NMD pathways and the involvement of more specialised NMD factors. We describe the consequences of mutations in NMD factors leading to neurodevelopmental diseases, and the role of NMD in cancer. We highlight strategies of RNA viruses to evade recognition and decay by the NMD machinery.

12 May 2022 in Biochemical Journal
Verified
Journal Article
Open access
PDF file
JMJustine Mailliot
Justine Mailliot
MVMirella Vivoli-Vega
Mirella Vivoli-Vega
CSChristiane Schaffitzel
Christiane Schaffitzel
Nonsense-mediated messenger RNA decay (NMD) represents one of the main surveillance pathways used by eukaryotic cells to control the quality and abundance of mRNAs and to degrade viral RNA. NMD recognises mRNAs with a premature termination codon (PTC) and targets them to decay. Markers for a mRNA with a PTC, and thus NMD, are a long a 3′-untranslated region and the presence of an exon-junction complex (EJC) downstream of the stop codon. Here, we review our structural understanding of mammalian NMD factors and their functional interplay leading to a branched network of different interconnected but specialised mRNA decay pathways. We discuss recent insights into the potential impact of EJC composition on NMD pathway choice. We highlight the coexistence and function of different isoforms of up-frameshift protein 1 (UPF1) with an emphasis of their role at the endoplasmic reticulum and during stress, and the role of the paralogs UPF3B and UPF3A, underscoring that gene regulation by mammalian NMD is tightly controlled and context-dependent being conditional on developmental stage, tissue and cell types.